Skip to content

Fusion Pharmaceuticals Inc.: filings

Every Fusion Pharmaceuticals Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 16 filings, each linked to its SEC index.

Filing record ends 2024-05-07

The latest filing in this captured record is a 10-Q filed 2024-05-07. No later filing is in the SEC companyfacts record captured on 2026-09-22. Fusion Pharmaceuticals Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-05-07fiscal Q1 202443890000950170-24-053958
10-K2024-03-20fiscal FY 2023491000000950170-24-034172
10-Q2023-11-07fiscal Q3 2023441290000950170-23-059777
10-Q2023-08-08fiscal Q2 2023441270000950170-23-039395
10-Q2023-05-11fiscal Q1 202343920000950170-23-020855
10-K2023-03-16fiscal FY 2022491000000950170-23-008310
10-Q2022-11-08fiscal Q3 2022461340000950170-22-022918
10-Q2022-08-09fiscal Q2 2022461300001564590-22-028594
10-Q2022-05-10fiscal Q1 202240820001564590-22-019082
10-K2022-03-17fiscal FY 202146910001564590-22-010720
10-Q2021-11-09fiscal Q3 2021421160001564590-21-055459
10-Q2021-08-10fiscal Q2 2021421110001564590-21-042893
10-Q2021-05-11fiscal Q1 202139800001564590-21-026297
10-K2021-03-25fiscal FY 202041820001564590-21-015271
10-Q2020-11-10fiscal Q3 2020371050001564590-20-052755
10-Q2020-08-11fiscal Q2 202033940001564590-20-039294

Inspect the source

Entity
Fusion Pharmaceuticals Inc. / CIK 0001805890
Captured
SEC response SHA-256
075ba5d7667e0fd4c32958463d9baf300738b5d45c7f2ccd68ef43cdba2ea599

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001805890.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))